Chronic Granulomatous Disease clinical trials

Explore recruiting chronic granulomatous disease clinical trials.

Recruiting chronic granulomatous disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Granulomatous Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase I/II, non randomized, monocentric open-label study of autologous CD34+ cells transduced with the G1XCGD lentiviral vector in patients with X-linked chronic granulomatous disease

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

An open-label, single-arm, phase 1/2 first-in-human study to assess the safety and efficacy of autologous CD34+ cells transduced with a lentiviral vector encoding the human NCF1 gene (SGX-001) in paediatric and adult patients with chronic granulomatous disease caused by p47phox deficiency

Germany, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Chronic Granulomatous Disease trials by city

Chronic Granulomatous Disease clinical trials

Recruiting chronic granulomatous disease studies right now

Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease

Lentiviral Gene Therapy for p47 AR-CGD

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease

Lentiviral Gene Therapy for CGD

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis

Also recruiting in Europe

A phase I/II, non randomized, monocentric open-label study of autologous CD34+ cells transduced with the G1XCGD lentiviral vector in patients with X-linked chronic granulomatous disease

An open-label, single-arm, phase 1/2 first-in-human study to assess the safety and efficacy of autologous CD34+ cells transduced with a lentiviral vector encoding the human NCF1 gene (SGX-001) in paediatric and adult patients with chronic granulomatous disease caused by p47phox deficiency

Chronic Granulomatous Disease trials by city

Other conditions